HomeOGEN • NYSEAMERICAN
Oragenics Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.68M | -6.23% |
Net income | -2.22M | 9.54% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.42M | 65.11% |
Total assets | 3.87M | 9.48% |
Total liabilities | 3.73M | 310.64% |
Total equity | 137.69K | — |
Shares outstanding | 21.48M | — |
Price to book | 20.20 | — |
Return on assets | -189.66% | — |
Return on capital | -360.70% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.22M | 9.54% |
Cash from operations | -2.11M | 31.07% |
Cash from investing | — | — |
Cash from financing | 4.67M | 182.46% |
Net change in cash | 2.56M | 281.10% |
Free cash flow | -1.29M | 40.34% |
Previous close
$0.20
Day range
$0.20 - $0.20
Year range
$0.16 - $2.98
Market cap
4.26M USD
Avg Volume
332.80K
P/E ratio
-
Dividend yield
-
About
Founded
1996
Headquarters
Website
Employees
4
